News

The psoriasis pipeline possesses some drugs in mid- and late-stage development to be approved in the near future. The emerging landscape holds a diverse range of therapeutic alternatives for treatment ...
Psoriasis doesn’t prevent you from having a cosmetic procedure, but there are safety and timing concerns to consider. Learn ...
If you’re experiencing a flaking, itching scalp, you may do a quick self-diagnosis of dandruff. But that flaking and itching ...
Organon Canada, a global healthcare company with a mission to improve the health of women throughout their lives, today announced that Health Canada has approved NDUVRA (tapinarof cream), 1%, the ...
Casey Gallagher, MD, a board-certified dermatologist and clinical professor, discusses how patients manage psoriasis and some ...
In the Phase III ICONIC-LEAD trial, 75% of adolescents with moderate-to-severe plaque psoriasis treated with icotrokinra ...
New data presented at the 2025 World Congress of Pediatric Dermatology annual meeting highlights the efficacy and safety of ...
Icotrokinra appears to be an effective treatment for adolescent patients with moderate to severe plaque psoriasis, according to a subgroup analysis of the ICONIC-LEAD study.
They found that topical application directly to the skin every day for seven days in an emollient ... Our findings raise the ...
Psoriasis shows on the skin, but it's a disease which goes a lot deeper and is linked to serious health problems. In recent years, newer targeted drugs are making a difference.
Lichenification occurs when repeated scratching or rubbing causes skin to thicken and become leathery. Certain skincare and ...
The study looked at a range of different diets and how they affected sufferers of the condition which causes flaky, scaly ...